Abstract: The present invention relates to new uses of modified human tumor necrosis factor receptor-1 (TNFRI) polypeptide, and more particularly, to uses thereof for prevention and treatment of dry eye syndrome. The modified TNFRI or modified TNFRI fragment of the present invention has excellent TNF? neutralizing activity, and inhibits TNF? activity on the ocular surface of the patient to suppress inflammation induction effects related to dry eye. Therefore, the modified TNFRI or modified TNFRI fragment of the present invention exhibits remarkable effects in the prevention and treatment of dry eye syndrome, and thus can be very useful in the prevention and treatment of dry eye syndrome.

Abstract: A liquid crystal display includes a first substrate, a gate line disposed on the first substrate, a data line disposed on the first substrate, a first passivation layer disposed on the gate line and the data line, a color filter disposed on the first passivation layer, a common electrode disposed on the color filter, a light blocking member disposed directly on or directly below the common electrode, a second passivation layer disposed on the common electrode and the light blocking member, and a pixel electrode disposed on the second passivation layer.

Abstract: A method and apparatus for managing power of a smart appliance is provided. The method includes acquiring, from the smart appliance, by an Energy Management System (EMS) for managing power of the smart appliance at home over a home network, terminal information including function information and power consumption information; monitoring power of the smart appliance and transmitting results of the results to an energy service provider; and controlling, upon receiving a power reduction command from the energy service provider, the power of the smart appliance based on the acquired terminal information.

Abstract: A touch sensing type liquid crystal display device includes an array substrate includes a first substrate, a common electrode, a pixel electrode, and a touch sensing unit; a color filter substrate including a second substrate and facing the array substrate; an anti-static layer on an outer side of the second substrate and including an organic material and a carbon nano-tube; and a liquid crystal layer between the first substrate and an inner side of the second substrate.

Abstract: Disclosed is a system and method for controlling Session Initiation Protocol (SIP)-specific event notification corresponding to an event subscription according to a preference of a subscriber. The system includes the subscriber requesting an event subscription through an event notification controller; a subscription target for notifying the subscriber of the event through the event notification controller in response to the event subscription request; and the event notification controller for controlling whether the event notification is forwarded to the subscriber according to the preference rules of the subscriber on event notifications. Accordingly, the event notifications to the subscriber can be effectively controlled according to the preference rules of the subscriber on event notifications, and it is possible to prevent the generation of unnecessary event notification that the subscriber does not desire.

Abstract: An N1-cyclic amine-N5-substituted phenyl biguanide derivative of Formula 1 or a pharmaceutically acceptable salt thereof, a method of manufacturing the same, and a pharmaceutical composition including the biguanide derivative or the pharmaceutically acceptable salt thereof as an active ingredient are provided. The biguanide derivatives have an effect of inhibiting cancer cell proliferation and also exhibit anticancer activity including inhibition of cancer metastasis and cancer recurrence, because they are effective in activating AMPK, which is associated with the control of energy metabolism, even when administered in a small dose compared with conventional drugs. Also, the biguanide derivatives are highly effective at lowering blood glucose and lipid concentration by AMPK activation, thus they may be effectively used to treat diabetes mellitus, obesity, hyperlipemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovary syndrome and metabolic syndrome.

Abstract: The present invention provides novel uses of a biguanide derivative for preventing or treating glioblastoma. The compound of Formula 1 and its pharmaceutically acceptable salts can be used for preventing and treating glioblastoma. Further, the combined treatment of the compound of Formula 1 and temozolomide can provide superior effects compared to the administration of the compound of Formula 1 alone or temozolomide alone.

Abstract: A quantum rod includes a core of ZnS semiconductor particle having a rod shape; and a transition metal with which the core is doped and which is biased at one side of a length direction of the core.

Abstract: The present invention provides a quantum rod including a core including zinc compound; and a shell covering the core and including ZnS. The quantum rod emits the short wavelength light.

Abstract: The present invention provides novel uses of a biguanide derivative for preventing or treating glioblastoma. The compound of Formula 1 and its pharmaceutically acceptable salts can be used for preventing and treating glioblastoma. Further, the combined treatment of the compound of Formula 1 and temozolomide can provide superior effects compared to the administration of the compound of Formula alone or temozolomide alone.

Abstract: A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK? and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.

Abstract: A biguanide derivative compound with N4-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK and inhibition of cancer cell proliferation in a low dose, compared with conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.

Abstract: Disclosed is remote management of a device by using another device that supports device management service as an intermediary. The device collects device information of said at least one device connected through a personal area network, converts the device information to converted device information of a form based on a device management protocol supported by the device management server, transfers the converted device information to the device management server, receives function management data related to said at least one device from the device management server, and transfers the received function management data to said at least one device through the personal area network.

Abstract: A transparent display device and a method of manufacturing the same are provided. The transparent display device includes: a display panel unit including: a first side configured to display an image, and a second side opposed to the first side, and a variable blocking film at the second side of the display panel unit, the variable blocking film including electrochromic core-shell nanoparticles.

Abstract: The present invention relates to a display device, and a manufacturing method thereof. The display device includes a first insulation substrate; gate lines and data lines positioned on the first insulating substrate. The gate lines and data lines are insulated from each other and crossed each other. A first passivation layer positioned on the gate lines and the data lines, and including a first contact opening. A color filter positioned on the first passivation layer, and including an opening. An organic insulation layer positioned on the color filter, and including a contact hole, in which the first contact opening is larger than the opening. The organic insulation layer covers the color filter and the contact opening.

Abstract: A method for providing a Device Management (DM) service in an M2M environment that enables intelligent data collection and communication through an M2M communication function is provided. In the method, a Network Operator Server (NOS) or an ES provides a DM service menu to a subscriber device. When the subscriber device selects a desired service from the DM service menu, the NOS delegates the DM service authority for a network subscriber to the ES. The ES provides the DM service through an M2M communication with the subscriber device. The ES integrates the DM results and transmits the integrated DM results to the network operator. Accordingly, the NOS can provide an efficient DM service to more devices at a lower cost, by minimal interaction with the ES, through the cooperation enterprise specialized in the DM service.

Abstract: Provided is a method for enabling a capability of a terminal in a device management system including a server capable of at least one of enabling and disabling capabilities of the terminal. The method includes the step of determining if a condition has been met for requesting enablement of a disabled capability of the terminal. The method further includes the step of transmitting a request message to the server including information related to the condition being met, based on a determination that the condition has been met. The method further includes the step of receiving a control command for the disabled capability from the server to process the control command.

Abstract: A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK? and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.

Abstract: A Converged-Internet Protocol (IP) Messaging (CPM) service provisioning method and system are provided including a CPM server. The CPM server includes an eXtension Markup Language (XML) Document Management (XDM) client for sending a request for preference information of a recipient terminal to which the CPM message is to be delivered, and receiving the preference information in response to the request from an XDM server that stores and manages the preference information of the recipient terminal; and an interworking selection entity for determining a non-CPM service to be subjected to interworking depending on the received preference information, and delivering the CPM message to an interworking server that interworks with the determined non-CPM service.

Abstract: A method and an apparatus for providing a contact through interworking with a Social Network Service (SNS) are provided. The method includes receiving, by a client using the other service through SNS interworking, a contact provided in the SNS, determining whether the other party's client having subscribed to the same service as that of the client is present in the received contact, and informing a user of the determination results. Based on the determination results, the client may determine subscription/non-subscription of the other party's client to the service, and may send an invite request for the service if the other party's client has not subscribed to the same service as that of the client. By doing so, the number of targets, subscription/non-subscription of which to a specific service can be determined, may be extended.